9 Ron Baron Abbvie Trades
The first Abbvie trade was made in Q1 2018. Since then Ron Baron bought shares four more times and sold shares on four occasions. The investor completely sold their stake between Q4 2022 and Q2 2023.
Avg closing price
Price range
Sold -15 Thousand shares
Q2 2023
Avg closing price
$146.64
Price range
$132.51
-
$164.90
Sold 62.9% shares (-25.4 Thousand shares)
Q1 2023
Avg closing price
$152.88
Price range
$144.61
-
$166.55
Sold 16.0% shares (-7.7 Thousand shares)
Q4 2022
Avg closing price
$153.33
Price range
$138.31
-
$165.99
Increased shares by 7.8% (+3.5 Thousand shares)
Q3 2022
Avg closing price
$143.50
Price range
$134.21
-
$153.93
Increased shares by 45.8% (+14 Thousand shares)
Q2 2022
Avg closing price
$152.80
Price range
$137.62
-
$174.96
New holding (+30.6 Thousand shares)
Q1 2022
Avg closing price
$145.26
Price range
$131.98
-
$163.75
Sold -754 shares
Q1 2019
Avg closing price
$81.81
Price range
$77.14
-
$90.79
Increased shares by 10.7% (+73 shares)
Q2 2018
Avg closing price
$97.66
Price range
$89.78
-
$106.23
New holding (+681 shares)
Q1 2018
Avg closing price
$109.85
Price range
$92.01
-
$123.21
News about Abbvie Inc and Ron Baron
Baron Funds: “Abbvie (ABBV) is Well Positioned for Growth”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. I...
Baron Funds: “We Retain Conviction in AbbVie (ABBV)”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.